[1]
H. Lee, P. Duggan, E. P. Neri, J. Tay, and V. Zepeda, “Bortezomib maintenance for the treatment of Monoclonal Gammopathy of Renal Significance”, MJHID, vol. 11, no. 1, p. e2019007, Jan. 2019.